Phreesia’s Danielle Lynch Named a ‘Sales MVP’ in PM360’s ELITE 100
ncarol.com/10173556

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named Danielle Lynch, Vice President, Client Experience, as one of the 2022 PM360 ELITE 100.

The PM360 ELITE Awards recognize the most influential people in the healthcare and life sciences industry today, and honorees were chosen from a pool of more than 500 submissions across 20 categories. The PM360 editorial staff selected winners based on their career accomplishments and the influence they've had on the industry.

Lynch was named in the "Sales MVPs" category, honoring leaders who are doing an outstanding job of building revenue and forming relationships that add to the growth of their company. Since helping Phreesia go public in 2019, Lynch has played a pivotal role in more than doubling the size of her Client Experience team and its bookings.

More on ncarol.com

• Nayarit Strengthens Its Position as a Global Surf Destination; Sayulita to Become Mexico's First Official Surf City
• Custom Cushions and Sewing Solutions Available in Cleveland County and Surrounding Areas
• Century Fasteners de Mexico Exhibiting at 2026 Farnborough International Airshow
• George Martinez Completes Community Re-distribution Initiative, Returning $5,000 In Campaign Resources To Anchorage Nonprofits
• Mister Omaha Tries The Turf At Lone Star Park

"I'm honored to be recognized by PM360, and I'm incredibly proud of the way the Client Experience team has contributed to the growth and success of Phreesia Life Sciences over the past few years," Lynch said.

Lynch has created a positive, collaborative culture through her team-based sales model, which operates without individual contributors and instead brings in talent from creative and media agency backgrounds who have worked on a wide range of brands, therapeutic categories and life cycles to achieve its quotas. Under her leadership, the Client Experience team has grown business across almost all of its accounts, and Phreesia's Life Sciences revenue has increased significantly, with approximately 77% expansion during fiscal year 2022.

"We are thrilled to see Danielle awarded this well-deserved honor," said David Linetsky, Phreesia's Senior Vice President, Life Sciences. "Her innovative approach to team building and client partnership are radically different than anything I've seen in other organizations. And despite rapidly scaling, she has managed to maintain the incredible team culture she pioneered to attract and retain some of the absolute best talent in the industry."

More on ncarol.com

• Andrew D. Levine Releases The Lily Network, an Indian Noir Mystery of Power, Paperwork & Murder
• The Mapping Software Behind America's Viral Maps Just Got Faster and Smarter
• Longevityresearch.ca publishes cross-disease causal analysis quantifying endpoint reduction across 27 diseases
• LEAN Culture Advisor Launches to Help Organizations Build High‑Performance, LEAN Workplace
• Joulescope JS320 Launches to Help Engineers Develop Battery-Powered Devices with Greater Confidence

About Phreesia Life Sciences

Phreesia empowers life sciences companies to connect meaningfully with clinically relevant patients, delivering targeted health content in a one-to-one setting. Our PatientConnect offering identifies and motivates the right patients to initiate meaningful brand conversations, and our PatientInsights product enables our clients to better understand their target patient populations.

Phreesia meets patients where they are, both virtually and in-person, and reaches them at multiple touchpoints throughout their healthcare journey. To learn more about Phreesia Life Sciences, visit lifesciences.phreesia.com.

Contacts

Media:
Carly Helfand
chelfand@phreesia.com
332-910-6768

---

Show All News | Disclaimer | Report Violation